Gelteq (GELS) Change in Intangibles (2023 - 2025)

Gelteq's (GELS) quarterly Change in Intangibles came in at -$49436.2 in Q4 2025, up 76.75% year-on-year from -$27970.0 in Q4 2024, and up 76.75% quarter-over-quarter from -$212604.6 in Q4 2024.

Gelteq (GELS) Change in Intangibles (2023 - 2025) Analysis & Trends

Gelteq's Change in Intangibles history runs 3 years deep, the most recent figure standing at -$49436.2 for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Haleon 89.24 Bn 87.37 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.16 Bn 1.97 Bn -
3 Zoetis 32.67 Bn 30.73 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.57 Bn 23.51 Bn 4.39 Bn -107.94 Mn
5 United Therapeutics 23.21 Bn 21.06 Bn 648.10 Mn -
6 RedHill Biopharma 20.54 Bn 20.54 Bn - -
7 Viatris 20.29 Bn 18.49 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.81 Bn 16.49 Bn 800.70 Mn -
9 Elanco Animal Health 12.58 Bn 12.15 Bn 785.00 Mn -
10 Gelteq 681.60 -47,880.04 - -49,436.20

Historic Data

Download Data
DateValue
Dec 31, 2025 -49,436.20
Dec 31, 2025 -49,436.20
Dec 31, 2024 -212,604.56
Dec 31, 2024 -212,604.56
Dec 31, 2023 -52,053.85
Dec 31, 2023 -52,053.85